nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbachol—PLA2G4A—Orlistat—type 2 diabetes mellitus	0.649	1	CbGbCtD
Carbachol—PLA2G4A—Glyburide—Tolazamide—type 2 diabetes mellitus	0.00129	0.17	CbGdCrCtD
Carbachol—PLA2G4A—Glyburide—Glimepiride—type 2 diabetes mellitus	0.00129	0.17	CbGdCrCtD
Carbachol—PLA2G4A—Glyburide—Glipizide—type 2 diabetes mellitus	0.00122	0.161	CbGdCrCtD
Carbachol—PLA2G4A—Glyburide—Gliclazide—type 2 diabetes mellitus	0.00122	0.161	CbGdCrCtD
Carbachol—PLA2G4A—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.00112	0.148	CbGdCrCtD
Carbachol—PLA2G4A—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000893	0.118	CbGdCrCtD
Carbachol—Hyponatraemia—Losartan—type 2 diabetes mellitus	0.000822	0.00397	CcSEcCtD
Carbachol—Rash—Tolbutamide—type 2 diabetes mellitus	0.000819	0.00396	CcSEcCtD
Carbachol—Sweating—Gliclazide—type 2 diabetes mellitus	0.000814	0.00394	CcSEcCtD
Carbachol—Headache—Tolbutamide—type 2 diabetes mellitus	0.000814	0.00393	CcSEcCtD
Carbachol—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000808	0.00391	CcSEcCtD
Carbachol—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.0008	0.00387	CcSEcCtD
Carbachol—Loss of consciousness—Glimepiride—type 2 diabetes mellitus	0.000788	0.00381	CcSEcCtD
Carbachol—Cramp muscle—Irbesartan—type 2 diabetes mellitus	0.000784	0.00379	CcSEcCtD
Carbachol—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000781	0.00378	CcSEcCtD
Carbachol—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000781	0.00378	CcSEcCtD
Carbachol—Muscle spasms—Bromocriptine—type 2 diabetes mellitus	0.000777	0.00376	CcSEcCtD
Carbachol—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000777	0.00375	CcSEcCtD
Carbachol—Sweating increased—Metformin—type 2 diabetes mellitus	0.000776	0.00375	CcSEcCtD
Carbachol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000771	0.00373	CcSEcCtD
Carbachol—Shock—Glipizide—type 2 diabetes mellitus	0.000771	0.00373	CcSEcCtD
Carbachol—Abdominal discomfort—Metformin—type 2 diabetes mellitus	0.000764	0.00369	CcSEcCtD
Carbachol—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000758	0.00366	CcSEcCtD
Carbachol—Asthma—Irbesartan—type 2 diabetes mellitus	0.000752	0.00364	CcSEcCtD
Carbachol—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000751	0.00363	CcSEcCtD
Carbachol—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000749	0.00362	CcSEcCtD
Carbachol—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000749	0.00362	CcSEcCtD
Carbachol—Infection—Pioglitazone—type 2 diabetes mellitus	0.000746	0.00361	CcSEcCtD
Carbachol—Rash—Tolazamide—type 2 diabetes mellitus	0.000745	0.0036	CcSEcCtD
Carbachol—Rash—Chlorpropamide—type 2 diabetes mellitus	0.000745	0.0036	CcSEcCtD
Carbachol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00074	0.00358	CcSEcCtD
Carbachol—Headache—Tolazamide—type 2 diabetes mellitus	0.00074	0.00358	CcSEcCtD
Carbachol—Cramp muscle—Losartan—type 2 diabetes mellitus	0.000737	0.00356	CcSEcCtD
Carbachol—Rash—Linagliptin—type 2 diabetes mellitus	0.000737	0.00356	CcSEcCtD
Carbachol—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000737	0.00356	CcSEcCtD
Carbachol—Headache—Linagliptin—type 2 diabetes mellitus	0.000732	0.00354	CcSEcCtD
Carbachol—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000726	0.00351	CcSEcCtD
Carbachol—Syncope—Bromocriptine—type 2 diabetes mellitus	0.000725	0.00351	CcSEcCtD
Carbachol—Infection—Sitagliptin—type 2 diabetes mellitus	0.000724	0.0035	CcSEcCtD
Carbachol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000724	0.0035	CcSEcCtD
Carbachol—Vomiting—Acarbose—type 2 diabetes mellitus	0.000722	0.00349	CcSEcCtD
Carbachol—Shock—Glimepiride—type 2 diabetes mellitus	0.00072	0.00348	CcSEcCtD
Carbachol—Rash—Acarbose—type 2 diabetes mellitus	0.000716	0.00346	CcSEcCtD
Carbachol—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000715	0.00346	CcSEcCtD
Carbachol—Loss of consciousness—Bromocriptine—type 2 diabetes mellitus	0.000711	0.00344	CcSEcCtD
Carbachol—Flushing—Gliclazide—type 2 diabetes mellitus	0.000708	0.00342	CcSEcCtD
Carbachol—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000707	0.00342	CcSEcCtD
Carbachol—Hyponatraemia—Ramipril—type 2 diabetes mellitus	0.000705	0.00341	CcSEcCtD
Carbachol—Nausea—Tolazamide—type 2 diabetes mellitus	0.000702	0.00339	CcSEcCtD
Carbachol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000702	0.00339	CcSEcCtD
Carbachol—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000696	0.00336	CcSEcCtD
Carbachol—Rash—Nateglinide—type 2 diabetes mellitus	0.00069	0.00334	CcSEcCtD
Carbachol—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.00069	0.00334	CcSEcCtD
Carbachol—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000689	0.00333	CcSEcCtD
Carbachol—Hypotension—Glimepiride—type 2 diabetes mellitus	0.000683	0.0033	CcSEcCtD
Carbachol—Arrhythmia—Gliclazide—type 2 diabetes mellitus	0.000681	0.00329	CcSEcCtD
Carbachol—Nausea—Acarbose—type 2 diabetes mellitus	0.000674	0.00326	CcSEcCtD
Carbachol—Pain—Glipizide—type 2 diabetes mellitus	0.00067	0.00324	CcSEcCtD
Carbachol—Infection—Bromocriptine—type 2 diabetes mellitus	0.000656	0.00317	CcSEcCtD
Carbachol—Flatulence—Gliclazide—type 2 diabetes mellitus	0.000654	0.00316	CcSEcCtD
Carbachol—Nausea—Nateglinide—type 2 diabetes mellitus	0.00065	0.00314	CcSEcCtD
Carbachol—Shock—Bromocriptine—type 2 diabetes mellitus	0.000649	0.00314	CcSEcCtD
Carbachol—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000648	0.00313	CcSEcCtD
Carbachol—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.000644	0.00311	CcSEcCtD
Carbachol—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000642	0.0031	CcSEcCtD
Carbachol—Cramp muscle—Ramipril—type 2 diabetes mellitus	0.000632	0.00306	CcSEcCtD
Carbachol—Pain—Sitagliptin—type 2 diabetes mellitus	0.000624	0.00301	CcSEcCtD
Carbachol—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.00062	0.003	CcSEcCtD
Carbachol—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000617	0.00298	CcSEcCtD
Carbachol—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000613	0.00296	CcSEcCtD
Carbachol—Asthma—Ramipril—type 2 diabetes mellitus	0.000607	0.00293	CcSEcCtD
Carbachol—Sweating—Losartan—type 2 diabetes mellitus	0.000605	0.00292	CcSEcCtD
Carbachol—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000602	0.00291	CcSEcCtD
Carbachol—Flatulence—Valsartan—type 2 diabetes mellitus	0.000601	0.0029	CcSEcCtD
Carbachol—Rash—Repaglinide—type 2 diabetes mellitus	0.000597	0.00289	CcSEcCtD
Carbachol—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000597	0.00288	CcSEcCtD
Carbachol—Flatulence—Orlistat—type 2 diabetes mellitus	0.000594	0.00287	CcSEcCtD
Carbachol—Headache—Repaglinide—type 2 diabetes mellitus	0.000593	0.00287	CcSEcCtD
Carbachol—Shock—Glyburide—type 2 diabetes mellitus	0.000593	0.00287	CcSEcCtD
Carbachol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000592	0.00286	CcSEcCtD
Carbachol—Flushing—Metformin—type 2 diabetes mellitus	0.000592	0.00286	CcSEcCtD
Carbachol—Sweating increased—Ramipril—type 2 diabetes mellitus	0.000591	0.00286	CcSEcCtD
Carbachol—Muscle spasms—Valsartan—type 2 diabetes mellitus	0.000586	0.00283	CcSEcCtD
Carbachol—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.000583	0.00282	CcSEcCtD
Carbachol—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000583	0.00282	CcSEcCtD
Carbachol—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000582	0.00281	CcSEcCtD
Carbachol—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000581	0.00281	CcSEcCtD
Carbachol—Muscle spasms—Orlistat—type 2 diabetes mellitus	0.000579	0.0028	CcSEcCtD
Carbachol—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000578	0.0028	CcSEcCtD
Carbachol—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000576	0.00279	CcSEcCtD
Carbachol—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000565	0.00273	CcSEcCtD
Carbachol—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000564	0.00273	CcSEcCtD
Carbachol—Hypotension—Glyburide—type 2 diabetes mellitus	0.000564	0.00272	CcSEcCtD
Carbachol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000563	0.00272	CcSEcCtD
Carbachol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000561	0.00271	CcSEcCtD
Carbachol—Flushing—Irbesartan—type 2 diabetes mellitus	0.000559	0.0027	CcSEcCtD
Carbachol—Flatulence—Metformin—type 2 diabetes mellitus	0.000547	0.00265	CcSEcCtD
Carbachol—Syncope—Valsartan—type 2 diabetes mellitus	0.000547	0.00264	CcSEcCtD
Carbachol—PLA2G4A—Enalapril—Ramipril—type 2 diabetes mellitus	0.000543	0.0716	CbGdCrCtD
Carbachol—Infection—Gliclazide—type 2 diabetes mellitus	0.000538	0.0026	CcSEcCtD
Carbachol—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000538	0.0026	CcSEcCtD
Carbachol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000536	0.00259	CcSEcCtD
Carbachol—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000536	0.00259	CcSEcCtD
Carbachol—Muscle spasms—Metformin—type 2 diabetes mellitus	0.000534	0.00258	CcSEcCtD
Carbachol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000532	0.00257	CcSEcCtD
Carbachol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000531	0.00257	CcSEcCtD
Carbachol—Flushing—Losartan—type 2 diabetes mellitus	0.000526	0.00254	CcSEcCtD
Carbachol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000524	0.00253	CcSEcCtD
Carbachol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000522	0.00252	CcSEcCtD
Carbachol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000522	0.00252	CcSEcCtD
Carbachol—Sweating—Ramipril—type 2 diabetes mellitus	0.000519	0.00251	CcSEcCtD
Carbachol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000518	0.00251	CcSEcCtD
Carbachol—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000516	0.0025	CcSEcCtD
Carbachol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000514	0.00248	CcSEcCtD
Carbachol—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000506	0.00245	CcSEcCtD
Carbachol—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000506	0.00245	CcSEcCtD
Carbachol—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000504	0.00244	CcSEcCtD
Carbachol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.0005	0.00242	CcSEcCtD
Carbachol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000499	0.00241	CcSEcCtD
Carbachol—Vomiting—Glipizide—type 2 diabetes mellitus	0.000498	0.00241	CcSEcCtD
Carbachol—Syncope—Metformin—type 2 diabetes mellitus	0.000498	0.00241	CcSEcCtD
Carbachol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000497	0.0024	CcSEcCtD
Carbachol—Infection—Valsartan—type 2 diabetes mellitus	0.000494	0.00239	CcSEcCtD
Carbachol—Rash—Glipizide—type 2 diabetes mellitus	0.000494	0.00239	CcSEcCtD
Carbachol—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000494	0.00239	CcSEcCtD
Carbachol—Headache—Glipizide—type 2 diabetes mellitus	0.000491	0.00237	CcSEcCtD
Carbachol—Shock—Valsartan—type 2 diabetes mellitus	0.00049	0.00237	CcSEcCtD
Carbachol—Infection—Orlistat—type 2 diabetes mellitus	0.000489	0.00236	CcSEcCtD
Carbachol—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000488	0.00236	CcSEcCtD
Carbachol—Flatulence—Losartan—type 2 diabetes mellitus	0.000486	0.00235	CcSEcCtD
Carbachol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000484	0.00234	CcSEcCtD
Carbachol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000482	0.00233	CcSEcCtD
Carbachol—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000477	0.00231	CcSEcCtD
Carbachol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000477	0.0023	CcSEcCtD
Carbachol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000475	0.0023	CcSEcCtD
Carbachol—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000474	0.00229	CcSEcCtD
Carbachol—Headache—Pioglitazone—type 2 diabetes mellitus	0.00047	0.00227	CcSEcCtD
Carbachol—Syncope—Irbesartan—type 2 diabetes mellitus	0.00047	0.00227	CcSEcCtD
Carbachol—Nausea—Glipizide—type 2 diabetes mellitus	0.000466	0.00225	CcSEcCtD
Carbachol—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000465	0.00225	CcSEcCtD
Carbachol—Hypotension—Valsartan—type 2 diabetes mellitus	0.000465	0.00225	CcSEcCtD
Carbachol—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000464	0.00224	CcSEcCtD
Carbachol—Pain—Gliclazide—type 2 diabetes mellitus	0.000463	0.00224	CcSEcCtD
Carbachol—Rash—Glimepiride—type 2 diabetes mellitus	0.000461	0.00223	CcSEcCtD
Carbachol—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000461	0.00223	CcSEcCtD
Carbachol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000461	0.00223	CcSEcCtD
Carbachol—Rash—Sitagliptin—type 2 diabetes mellitus	0.00046	0.00222	CcSEcCtD
Carbachol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000459	0.00222	CcSEcCtD
Carbachol—Headache—Glimepiride—type 2 diabetes mellitus	0.000458	0.00222	CcSEcCtD
Carbachol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000457	0.00221	CcSEcCtD
Carbachol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000451	0.00218	CcSEcCtD
Carbachol—Flushing—Ramipril—type 2 diabetes mellitus	0.000451	0.00218	CcSEcCtD
Carbachol—Infection—Metformin—type 2 diabetes mellitus	0.00045	0.00218	CcSEcCtD
Carbachol—Shock—Metformin—type 2 diabetes mellitus	0.000446	0.00216	CcSEcCtD
Carbachol—Syncope—Losartan—type 2 diabetes mellitus	0.000442	0.00214	CcSEcCtD
Carbachol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000438	0.00212	CcSEcCtD
Carbachol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000438	0.00212	CcSEcCtD
Carbachol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000436	0.00211	CcSEcCtD
Carbachol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000434	0.0021	CcSEcCtD
Carbachol—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000434	0.0021	CcSEcCtD
Carbachol—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000433	0.0021	CcSEcCtD
Carbachol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000433	0.00209	CcSEcCtD
Carbachol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000433	0.00209	CcSEcCtD
Carbachol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000428	0.00207	CcSEcCtD
Carbachol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000428	0.00207	CcSEcCtD
Carbachol—Infection—Irbesartan—type 2 diabetes mellitus	0.000425	0.00205	CcSEcCtD
Carbachol—Hypotension—Metformin—type 2 diabetes mellitus	0.000423	0.00205	CcSEcCtD
Carbachol—Shock—Irbesartan—type 2 diabetes mellitus	0.000421	0.00203	CcSEcCtD
Carbachol—Pain—Orlistat—type 2 diabetes mellitus	0.000421	0.00203	CcSEcCtD
Carbachol—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00042	0.00203	CcSEcCtD
Carbachol—Rash—Bromocriptine—type 2 diabetes mellitus	0.000416	0.00201	CcSEcCtD
Carbachol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000416	0.00201	CcSEcCtD
Carbachol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000413	0.002	CcSEcCtD
Carbachol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000413	0.002	CcSEcCtD
Carbachol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000413	0.002	CcSEcCtD
Carbachol—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000407	0.00197	CcSEcCtD
Carbachol—Infection—Losartan—type 2 diabetes mellitus	0.0004	0.00193	CcSEcCtD
Carbachol—Hypotension—Irbesartan—type 2 diabetes mellitus	0.0004	0.00193	CcSEcCtD
Carbachol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000399	0.00193	CcSEcCtD
Carbachol—Shock—Losartan—type 2 diabetes mellitus	0.000396	0.00191	CcSEcCtD
Carbachol—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000393	0.0019	CcSEcCtD
Carbachol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000392	0.00189	CcSEcCtD
Carbachol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000389	0.00188	CcSEcCtD
Carbachol—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000389	0.00188	CcSEcCtD
Carbachol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000389	0.00188	CcSEcCtD
Carbachol—Vomiting—Glyburide—type 2 diabetes mellitus	0.000384	0.00185	CcSEcCtD
Carbachol—Rash—Glyburide—type 2 diabetes mellitus	0.00038	0.00184	CcSEcCtD
Carbachol—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00038	0.00184	CcSEcCtD
Carbachol—Syncope—Ramipril—type 2 diabetes mellitus	0.000379	0.00183	CcSEcCtD
Carbachol—Headache—Glyburide—type 2 diabetes mellitus	0.000378	0.00183	CcSEcCtD
Carbachol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000376	0.00182	CcSEcCtD
Carbachol—Hypotension—Losartan—type 2 diabetes mellitus	0.000376	0.00182	CcSEcCtD
Carbachol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000372	0.0018	CcSEcCtD
Carbachol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000371	0.00179	CcSEcCtD
Carbachol—Pain—Irbesartan—type 2 diabetes mellitus	0.000366	0.00177	CcSEcCtD
Carbachol—Nausea—Glyburide—type 2 diabetes mellitus	0.000358	0.00173	CcSEcCtD
Carbachol—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000358	0.00173	CcSEcCtD
Carbachol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000358	0.00173	CcSEcCtD
Carbachol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000354	0.00171	CcSEcCtD
Carbachol—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000344	0.00166	CcSEcCtD
Carbachol—Pain—Losartan—type 2 diabetes mellitus	0.000344	0.00166	CcSEcCtD
Carbachol—Rash—Gliclazide—type 2 diabetes mellitus	0.000342	0.00165	CcSEcCtD
Carbachol—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000341	0.00165	CcSEcCtD
Carbachol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000341	0.00165	CcSEcCtD
Carbachol—Shock—Ramipril—type 2 diabetes mellitus	0.00034	0.00164	CcSEcCtD
Carbachol—Headache—Gliclazide—type 2 diabetes mellitus	0.000339	0.00164	CcSEcCtD
Carbachol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000338	0.00163	CcSEcCtD
Carbachol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000338	0.00163	CcSEcCtD
Carbachol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000336	0.00163	CcSEcCtD
Carbachol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000334	0.00161	CcSEcCtD
Carbachol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000329	0.00159	CcSEcCtD
Carbachol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000325	0.00157	CcSEcCtD
Carbachol—Hypotension—Ramipril—type 2 diabetes mellitus	0.000322	0.00156	CcSEcCtD
Carbachol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000322	0.00156	CcSEcCtD
Carbachol—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000318	0.00154	CcSEcCtD
Carbachol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000318	0.00154	CcSEcCtD
Carbachol—Vomiting—Valsartan—type 2 diabetes mellitus	0.000316	0.00153	CcSEcCtD
Carbachol—Rash—Valsartan—type 2 diabetes mellitus	0.000314	0.00152	CcSEcCtD
Carbachol—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000313	0.00152	CcSEcCtD
Carbachol—Vomiting—Orlistat—type 2 diabetes mellitus	0.000313	0.00151	CcSEcCtD
Carbachol—Headache—Valsartan—type 2 diabetes mellitus	0.000312	0.00151	CcSEcCtD
Carbachol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00031	0.0015	CcSEcCtD
Carbachol—Rash—Orlistat—type 2 diabetes mellitus	0.00031	0.0015	CcSEcCtD
Carbachol—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00031	0.0015	CcSEcCtD
Carbachol—Headache—Orlistat—type 2 diabetes mellitus	0.000308	0.00149	CcSEcCtD
Carbachol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000304	0.00147	CcSEcCtD
Carbachol—Dizziness—Metformin—type 2 diabetes mellitus	0.0003	0.00145	CcSEcCtD
Carbachol—Nausea—Valsartan—type 2 diabetes mellitus	0.000296	0.00143	CcSEcCtD
Carbachol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000293	0.00141	CcSEcCtD
Carbachol—Nausea—Orlistat—type 2 diabetes mellitus	0.000292	0.00141	CcSEcCtD
Carbachol—Vomiting—Metformin—type 2 diabetes mellitus	0.000288	0.00139	CcSEcCtD
Carbachol—Rash—Metformin—type 2 diabetes mellitus	0.000286	0.00138	CcSEcCtD
Carbachol—Dermatitis—Metformin—type 2 diabetes mellitus	0.000285	0.00138	CcSEcCtD
Carbachol—Headache—Metformin—type 2 diabetes mellitus	0.000284	0.00137	CcSEcCtD
Carbachol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000283	0.00137	CcSEcCtD
Carbachol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000275	0.00133	CcSEcCtD
Carbachol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000273	0.00132	CcSEcCtD
Carbachol—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000273	0.00132	CcSEcCtD
Carbachol—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000272	0.00131	CcSEcCtD
Carbachol—Rash—Irbesartan—type 2 diabetes mellitus	0.00027	0.0013	CcSEcCtD
Carbachol—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000269	0.0013	CcSEcCtD
Carbachol—Nausea—Metformin—type 2 diabetes mellitus	0.000269	0.0013	CcSEcCtD
Carbachol—Headache—Irbesartan—type 2 diabetes mellitus	0.000268	0.0013	CcSEcCtD
Carbachol—Dizziness—Losartan—type 2 diabetes mellitus	0.000266	0.00129	CcSEcCtD
Carbachol—Vomiting—Losartan—type 2 diabetes mellitus	0.000256	0.00124	CcSEcCtD
Carbachol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000254	0.00123	CcSEcCtD
Carbachol—Rash—Losartan—type 2 diabetes mellitus	0.000254	0.00123	CcSEcCtD
Carbachol—Dermatitis—Losartan—type 2 diabetes mellitus	0.000254	0.00123	CcSEcCtD
Carbachol—Headache—Losartan—type 2 diabetes mellitus	0.000252	0.00122	CcSEcCtD
Carbachol—Nausea—Losartan—type 2 diabetes mellitus	0.000239	0.00116	CcSEcCtD
Carbachol—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000236	0.00114	CcSEcCtD
Carbachol—Dizziness—Ramipril—type 2 diabetes mellitus	0.000228	0.0011	CcSEcCtD
Carbachol—Vomiting—Ramipril—type 2 diabetes mellitus	0.000219	0.00106	CcSEcCtD
Carbachol—Rash—Ramipril—type 2 diabetes mellitus	0.000218	0.00105	CcSEcCtD
Carbachol—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000217	0.00105	CcSEcCtD
Carbachol—Headache—Ramipril—type 2 diabetes mellitus	0.000216	0.00105	CcSEcCtD
Carbachol—Nausea—Ramipril—type 2 diabetes mellitus	0.000205	0.000991	CcSEcCtD
Carbachol—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	2e-05	0.000146	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.99e-05	0.000146	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.99e-05	0.000145	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.97e-05	0.000144	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.97e-05	0.000144	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.97e-05	0.000144	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.96e-05	0.000143	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.96e-05	0.000143	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—INS—type 2 diabetes mellitus	1.96e-05	0.000143	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.96e-05	0.000143	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.96e-05	0.000143	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.96e-05	0.000143	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.95e-05	0.000143	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.95e-05	0.000143	CbGpPWpGaD
Carbachol—PLA2G4A—Hemostasis—AKT1—type 2 diabetes mellitus	1.95e-05	0.000143	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.94e-05	0.000142	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.94e-05	0.000141	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.94e-05	0.000141	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.93e-05	0.000141	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.93e-05	0.000141	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.92e-05	0.00014	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.92e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.92e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.92e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.92e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.91e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.91e-05	0.00014	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.9e-05	0.000139	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.9e-05	0.000139	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.9e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.89e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.89e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.89e-05	0.000138	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.87e-05	0.000137	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.84e-05	0.000135	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.84e-05	0.000134	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.82e-05	0.000133	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.81e-05	0.000132	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	1.8e-05	0.000132	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.8e-05	0.000132	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—ALB—type 2 diabetes mellitus	1.8e-05	0.000131	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	1.8e-05	0.000131	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.79e-05	0.00013	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.78e-05	0.00013	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.78e-05	0.00013	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.77e-05	0.000129	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	1.77e-05	0.000129	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.76e-05	0.000129	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.76e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.76e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.75e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.75e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	1.75e-05	0.000128	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	1.73e-05	0.000127	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.73e-05	0.000127	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.73e-05	0.000126	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.72e-05	0.000126	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.72e-05	0.000126	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.72e-05	0.000126	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—NOS3—type 2 diabetes mellitus	1.72e-05	0.000126	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	1.72e-05	0.000126	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.72e-05	0.000125	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.71e-05	0.000125	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.7e-05	0.000125	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.7e-05	0.000124	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	1.67e-05	0.000122	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.64e-05	0.00012	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	1.64e-05	0.00012	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—INS—type 2 diabetes mellitus	1.64e-05	0.00012	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.64e-05	0.00012	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.62e-05	0.000118	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.61e-05	0.000118	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.61e-05	0.000118	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.61e-05	0.000118	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.61e-05	0.000118	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	1.61e-05	0.000117	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.61e-05	0.000117	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	1.6e-05	0.000117	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.59e-05	0.000116	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.59e-05	0.000116	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.59e-05	0.000116	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.59e-05	0.000116	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.58e-05	0.000115	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—PTGS2—type 2 diabetes mellitus	1.57e-05	0.000115	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	1.56e-05	0.000114	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	1.54e-05	0.000113	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.53e-05	0.000112	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.52e-05	0.000111	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.51e-05	0.000111	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.51e-05	0.00011	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.51e-05	0.00011	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.51e-05	0.00011	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.49e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.49e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.49e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	1.49e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.49e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.49e-05	0.000109	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.48e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.48e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	1.48e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.47e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	1.47e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.47e-05	0.000108	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.47e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.46e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.46e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.46e-05	0.000107	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	1.45e-05	0.000106	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.45e-05	0.000106	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	1.44e-05	0.000105	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.44e-05	0.000105	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.44e-05	0.000105	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	1.44e-05	0.000105	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.44e-05	0.000105	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.43e-05	0.000105	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	1.42e-05	0.000104	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.42e-05	0.000104	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.42e-05	0.000104	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.41e-05	0.000103	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	1.4e-05	0.000103	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.4e-05	0.000102	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	1.38e-05	0.000101	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	1.38e-05	0.000101	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	1.38e-05	0.000101	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	1.37e-05	0.0001	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	1.36e-05	9.94e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	1.36e-05	9.93e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.35e-05	9.9e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.35e-05	9.85e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.34e-05	9.82e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.33e-05	9.72e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.29e-05	9.44e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.29e-05	9.41e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.28e-05	9.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.27e-05	9.27e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.26e-05	9.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.25e-05	9.15e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	1.24e-05	9.06e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	1.24e-05	9.03e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	1.22e-05	8.94e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-05	8.93e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.21e-05	8.87e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	1.2e-05	8.76e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.18e-05	8.64e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.18e-05	8.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.18e-05	8.61e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	1.18e-05	8.61e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.18e-05	8.59e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—INS—type 2 diabetes mellitus	1.18e-05	8.59e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	1.17e-05	8.58e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.17e-05	8.53e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.16e-05	8.51e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.16e-05	8.5e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.16e-05	8.46e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.15e-05	8.44e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.15e-05	8.44e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	1.15e-05	8.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	1.15e-05	8.43e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	1.15e-05	8.41e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	1.15e-05	8.41e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.14e-05	8.35e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-05	8.35e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.14e-05	8.34e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.14e-05	8.33e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.14e-05	8.33e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.14e-05	8.31e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.13e-05	8.23e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-05	8.18e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.09e-05	7.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.09e-05	7.93e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	1.08e-05	7.87e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.07e-05	7.85e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.06e-05	7.78e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-05	7.57e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.03e-05	7.53e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	1.03e-05	7.53e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.03e-05	7.52e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.03e-05	7.5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.02e-05	7.43e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	9.86e-06	7.21e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	9.83e-06	7.18e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	9.74e-06	7.11e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.7e-06	7.09e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.67e-06	7.07e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	9.58e-06	7e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.54e-06	6.97e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.53e-06	6.96e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.52e-06	6.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.51e-06	6.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.5e-06	6.94e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.49e-06	6.93e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.46e-06	6.91e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	9.43e-06	6.89e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	9.42e-06	6.88e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	9.41e-06	6.87e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	9.37e-06	6.85e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.33e-06	6.82e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.06e-06	6.62e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	9.03e-06	6.6e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	8.94e-06	6.53e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.65e-06	6.32e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.65e-06	6.32e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.62e-06	6.3e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.62e-06	6.3e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	8.54e-06	6.24e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	8.54e-06	6.24e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	8.14e-06	5.95e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	8.11e-06	5.93e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	8.04e-06	5.87e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Metabolism—AKT1—type 2 diabetes mellitus	7.91e-06	5.78e-05	CbGpPWpGaD
Carbachol—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.41e-06	5.41e-05	CbGpPWpGaD
Carbachol—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.39e-06	5.4e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.34e-06	5.36e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.32e-06	5.35e-05	CbGpPWpGaD
Carbachol—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	7.32e-06	5.34e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.29e-06	5.33e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.27e-06	5.31e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	7.25e-06	5.3e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	7.2e-06	5.26e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.17e-06	5.24e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.94e-06	5.07e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.92e-06	5.05e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.87e-06	5.02e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	6.85e-06	5e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.84e-06	5e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	6.78e-06	4.95e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.73e-06	4.92e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.71e-06	4.9e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	6.64e-06	4.85e-05	CbGpPWpGaD
Carbachol—PLA2G4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.61e-06	4.83e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	6.4e-06	4.67e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	6.38e-06	4.66e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	6.31e-06	4.61e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.23e-06	4.55e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.21e-06	4.54e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	6.15e-06	4.49e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.72e-06	4.18e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.7e-06	4.16e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	5.65e-06	4.12e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.61e-06	4.1e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.59e-06	4.08e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	5.53e-06	4.04e-05	CbGpPWpGaD
Carbachol—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	4.74e-06	3.46e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	4.31e-06	3.15e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	4.3e-06	3.14e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	4.25e-06	3.11e-05	CbGpPWpGaD
Carbachol—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.98e-06	2.9e-05	CbGpPWpGaD
Carbachol—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.96e-06	2.9e-05	CbGpPWpGaD
Carbachol—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.92e-06	2.87e-05	CbGpPWpGaD
